• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

2019年冠状病毒病大流行期间在全国范围内实施非药物干预措施与肾移植受者肺炎发病率降低相关。

Nationwide Implementation of Nonpharmaceutical Interventions During the Coronavirus Disease 2019 Pandemic Is Associated With Decreased Incidence of Pneumonia in Kidney Transplant Recipients.

作者信息

Park Keun Hyung, Jung Chan-Young, Jeong Wonjeong, Lee Gongmyung, Yang Jae Seok, Nam Chung Mo, Kim Hyung Woo, Kim Beom Seok

机构信息

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea.

Department of Public Health, Graduate School, Yonsei University, Seoul, Republic of Korea.

出版信息

Open Forum Infect Dis. 2022 Jun 23;9(6):ofac076. doi: 10.1093/ofid/ofac076. eCollection 2022 Jun.

DOI:10.1093/ofid/ofac076
PMID:35770128
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9223043/
Abstract

This study aimed to investigate the impact of nationwide nonpharmaceutical interventions against coronavirus disease 2019 (COVID-19) on the incidence of pneumonia (PCP) in kidney transplant recipients. The monthly incidence of PCP during the COVID-19 period decreased significantly compared to that of the pre-COVID-19 period in kidney transplant recipients.

摘要

本研究旨在调查全国范围内针对2019冠状病毒病（COVID-19）的非药物干预措施对肾移植受者肺炎（PCP）发病率的影响。与COVID-19之前的时期相比，肾移植受者在COVID-19期间PCP的月发病率显著下降。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99b5/9223043/7ace559d8903/ofac076_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99b5/9223043/7ace559d8903/ofac076_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/99b5/9223043/7ace559d8903/ofac076_fig1.jpg

相似文献

1
Nationwide Implementation of Nonpharmaceutical Interventions During the Coronavirus Disease 2019 Pandemic Is Associated With Decreased Incidence of Pneumonia in Kidney Transplant Recipients.2019年冠状病毒病大流行期间在全国范围内实施非药物干预措施与肾移植受者肺炎发病率降低相关。
Open Forum Infect Dis. 2022 Jun 23;9(6):ofac076. doi: 10.1093/ofid/ofac076. eCollection 2022 Jun.
2
Genetic and Epidemiologic Analyses of an Outbreak of Pneumocystis jirovecii Pneumonia Among Kidney Transplant Recipients in the United States.美国一起肾移植受者肺孢子菌肺炎暴发的遗传与流行病学分析。
Clin Infect Dis. 2022 Mar 1;74(4):639-647. doi: 10.1093/cid/ciab474.
3
Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.接受6个月甲氧苄啶-磺胺甲恶唑预防治疗的肾移植受者中与耶氏肺孢子菌肺炎相关的流行病学及危险因素：一项病例对照研究
Transpl Infect Dis. 2020 Apr;22(2):e13245. doi: 10.1111/tid.13245. Epub 2020 Jan 24.
4
Pneumocystis jirovecii pneumonia in renal transplant recipients: a national center experience.肾移植受者中的耶氏肺孢子菌肺炎：一家国家中心的经验
Transplant Proc. 2013 May;45(4):1614-7. doi: 10.1016/j.transproceed.2013.02.107.
5
Pneumocystis jirovecii pneumonia in liver transplant recipients in an era of routine prophylaxis.在常规预防时代，肝移植受者中的卡氏肺孢子菌肺炎。
Immun Inflamm Dis. 2022 Jan;10(1):93-100. doi: 10.1002/iid3.546. Epub 2021 Oct 29.
6
Lifelong Prophylaxis With Trimethoprim-Sulfamethoxazole for Prevention of Outbreak of Pneumonia in Kidney Transplant Recipients.使用甲氧苄啶-磺胺甲恶唑进行终身预防以防止肾移植受者发生肺炎暴发
Transplant Direct. 2017 Apr 5;3(5):e151. doi: 10.1097/TXD.0000000000000665. eCollection 2017 May.
7
Epidemiological Outbreaks of Pneumocystis jirovecii Pneumonia Are Not Limited to Kidney Transplant Recipients: Genotyping Confirms Common Source of Transmission in a Liver Transplantation Unit.耶氏肺孢子菌肺炎的流行病学暴发并不局限于肾移植受者：基因分型证实了一家肝移植单位存在共同传播源。
J Clin Microbiol. 2016 May;54(5):1314-20. doi: 10.1128/JCM.00133-16. Epub 2016 Mar 2.
8
Genetic diversity of Pneumocystis jirovecii from a cluster of cases of pneumonia in renal transplant patients: Cross-sectional study.肺孢子菌肺炎在肾移植患者中的流行情况及危险因素分析：一项横断面研究
Mycoses. 2018 Nov;61(11):845-852. doi: 10.1111/myc.12823. Epub 2018 Jul 27.
9
Changing Trends in the Incidence and Clinical Features of Pneumonia in Non-HIV Patients before and during the COVID-19 Era and Risk Factors for Mortality between 2016 and 2022.2016年至2022年间，非HIV患者在COVID-19大流行之前和期间肺炎发病率及临床特征的变化趋势以及死亡风险因素
Life (Basel). 2023 Jun 7;13(6):1335. doi: 10.3390/life13061335.
10
Pneumocystis jirovecii colonization among renal transplant recipients.肺孢子菌定植于肾移植受者。
Nephrology (Carlton). 2013 May;18(5):382-7. doi: 10.1111/nep.12054.

引用本文的文献

1
The effect of COVID-19 on the frequency of Pneumocystis jirovecii pneumonia: a monocentric, retrospective, and observational study.COVID-19 对卡氏肺孢子虫肺炎发生频率的影响：一项单中心、回顾性、观察性研究。
BMC Infect Dis. 2023 Oct 17;23(1):693. doi: 10.1186/s12879-023-08545-w.
2
Changing Trends in the Incidence and Clinical Features of Pneumonia in Non-HIV Patients before and during the COVID-19 Era and Risk Factors for Mortality between 2016 and 2022.2016年至2022年间，非HIV患者在COVID-19大流行之前和期间肺炎发病率及临床特征的变化趋势以及死亡风险因素
Life (Basel). 2023 Jun 7;13(6):1335. doi: 10.3390/life13061335.

本文引用的文献

1
Reduction in Kawasaki Disease After Nonpharmaceutical Interventions in the COVID-19 Era: A Nationwide Observational Study in Korea.新冠疫情时代非药物干预后川崎病发病率的下降：韩国一项全国性观察性研究
Circulation. 2021 Jun 22;143(25):2508-2510. doi: 10.1161/CIRCULATIONAHA.121.054785. Epub 2021 Jun 7.
2
Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review.单独隔离或与其他公共卫生措施相结合以控制新冠病毒病：一项快速综述
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013574. doi: 10.1002/14651858.CD013574.pub2.
3
The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections.
新冠疫情非药物干预措施对地方性感染未来动态的影响。
Proc Natl Acad Sci U S A. 2020 Dec 1;117(48):30547-30553. doi: 10.1073/pnas.2013182117. Epub 2020 Nov 9.
4
Impact of Nonpharmaceutical Interventions on the Incidence of Respiratory Infections During the Coronavirus Disease 2019 (COVID-19) Outbreak in Korea: A Nationwide Surveillance Study.非药物干预对韩国 2019 年冠状病毒病（COVID-19）爆发期间呼吸道感染发病率的影响：一项全国性监测研究。
Clin Infect Dis. 2021 Apr 8;72(7):e184-e191. doi: 10.1093/cid/ciaa1682.
5
Decreased Influenza Activity During the COVID-19 Pandemic - United States, Australia, Chile, and South Africa, 2020.新冠疫情期间流感活动减少——美国、澳大利亚、智利和南非，2020 年。
MMWR Morb Mortal Wkly Rep. 2020 Sep 18;69(37):1305-1309. doi: 10.15585/mmwr.mm6937a6.
6
Respiratory viruses in transplant recipients: more than just a cold. Clinical syndromes and infection prevention principles.移植受者中的呼吸道病毒：不仅仅是感冒。临床综合征及感染预防原则。
Int J Infect Dis. 2017 Sep;62:86-93. doi: 10.1016/j.ijid.2017.07.011. Epub 2017 Jul 22.
7
Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial.干细胞移植后普遍使用口罩以减少呼吸道病毒感染：一项前瞻性试验。
Clin Infect Dis. 2016 Oct 15;63(8):999-1006. doi: 10.1093/cid/ciw451. Epub 2016 Aug 1.
8
Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P. jiroveci is contagious to the susceptible host.肾移植受者中耶氏肺孢子菌肺炎的暴发：耶氏肺孢子菌对易感宿主具有传染性。
Transplantation. 2009 Aug 15;88(3):380-5. doi: 10.1097/TP.0b013e3181aed389.
9
Analysis of USRDS: incidence and risk factors for Pneumocystis jiroveci pneumonia.美国肾脏数据系统分析：耶氏肺孢子菌肺炎的发病率及危险因素
Transplantation. 2009 Jul 15;88(1):135-41. doi: 10.1097/TP.0b013e3181aad256.
10
Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients.预防人类免疫缺陷病毒阴性免疫功能低下患者发生肺孢子菌属感染。
Clin Microbiol Rev. 2004 Oct;17(4):770-82, table of contents. doi: 10.1128/CMR.17.4.770-782.2004.